Cellular Respiration in Thymic Fragments from Mice

Area of Science:

• Immunology
• Pharmacology
• Biochemistry

Background:

• Investigating in vitro thymic responses to pharmaceutical agents is crucial for understanding immune modulation.
• Sirolimus (mTOR inhibitor) and ozanimod (S1P receptor agonist) are key immunomodulatory drugs with distinct mechanisms of action.

Purpose of the Study:

• To detail the use of phosphorescence oxygen analyzer for in vitro thymic response assessment.
• To evaluate the impact of sirolimus and ozanimod on thymocyte respiration.

Main Methods:

• In vitro incubation of mouse thymic fragments in oxygen-sensing medium.
• Monitoring cellular oxygen consumption over time using phosphorescence oxygen analyzer.
• Quantifying thymocyte respiration rate (μM O2 min-1 mg-1) and assessing inhibition by pharmaceutical agents.

Main Results:

• Thymocyte respiration rate was linear and confirmed to be cytochrome oxidase-dependent.
• Baseline thymocyte respiration rate in control mice was established (0.046 ± 0.011 μM O2 min-1 mg-1).
• Sirolimus inhibited respiration by 16%, and ozanimod by 29% in thymic fragments.

Conclusions:

• Thymocyte respiration serves as a valid surrogate biomarker for evaluating drug effects.
• This method aids in studying the mode-of-action and cytotoxicity of immunosuppressants and immunomodulators.
• Phosphorescence oxygen analysis offers a sensitive tool for in vitro drug screening in immunology.